Clinical Trial Update: Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study of sirolimus in pediatric patients with relapsed or refractory acute leukemia or non-Hodgkin's lymphoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Leukemia, Lymphoma | Phase 1 | Status: TERMINATED